Before visiting our News and Events pages, please confirm that you are a healthcare professional.
Before visiting our Covid-19 News page, please confirm that you are a healthcare professional.
| Alacare® 5-aminolevulinic acid | Alacare® contains the active substance 5-aminolevulinic acid It is available as a medicated plaster | Click here to view the Alacare® SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Bortezomib | Bortezomib is avaliable as a powder for solution for injection | Click here to view the Bortezomib SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Carmustine Obvius | Carmustine Obvius is available as a powder and solvent for concentrate for solution for infusion | Click here to view the Carmustine Obvius SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Dacarbazine | Dacarbazine is available as a powder for solution for injection/infusion | Click here to view the Dacarbazine SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Doxorubicin | Doxorubicin is available as a solution for infusion | Click here to view the Doxorubicin SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Epirubicin | Epirubucin is available as a solution for injection | Click here to view the Epirubicin SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Etoposide | Etoposide is available as a concentrate for solution for infusion | Click here to view the Etoposide SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Fluorouracil | Fluorouracil is available as a solution for injection | Click here to view the Fluorouracil 25mg/ml SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. Click here to view the Fluorouracil 50mg/ml SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. Click here to view the direct healthcare professional communication: I am a UK healthcare professional NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Gliolan® 5-aminolevulinic acid | Gliolan® contains the active substance 5-aminolevulinic acid Gliolan® is available as a powder for oral solution | Click here to view the Gliolan® SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Hydroxycarbamide | Hydroxycarbamide is available as capsules | Click here to view the Hydroxycarbamide SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Irinotecan | Irinotecan is available as a concentrate for solution for infusion | Click here to view the Irinotecan SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Leflunomide medac 15mg Leflunomide | Leflunomide medac 15mg contains the active substance leflunomide It is available as film-coated tablets | Click here to view the Leflunomide 15mg SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. Click here to view the risk minimisation patient leaflet |
| Levofolinic acid Disodium Levofolinate | Levofolinic acid contains the active substance disodium levofolinate It is available as a solution for injection/infusion | Click here to view the Levofolinic acid SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Lomustine | Lomustine is available as capsules | Click here to view the Lomustine SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Methotrexate Solution | Methotrexate is available as a solution for injection | Click here to view the Methotrexate Solution SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Metoject® PEN Methotrexate | Metoject® PEN contains the active substance methotrexate It is available as a solution for injection in pre-filled pen | Click here to view the Metoject® PEN SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Mitomycin medac Mitomycin | Mitomycin medac contains the active substance mitomycin It is available as a powder and solvent for intravesical solution | Click here to view the Mitomycin medac SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Oxaliplatin | Oxaliplatin is available as a concentrate for solution for infusion | Click here to view the Oxaliplatin SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Sodiofolin Sodium Folinate | Sodiofolin contains the active substance disodium folinate It is available as a solution for injection/infusion | Click here to view the Sodiofolin SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Spectrila® Asparaginase | Spectrila® contains the active substance asparaginase It is available as a powder for concentrate for solution for infusion | Click here to view the Spectrila® SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Trecondi® Treosulfan | Trecondi® contains the active substance treosulfan It is available as a powder for solution for infusion | Click here to view the Trecondi® SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Treosulfan | Treosulfan is available as capsules | Click here to view the Treosulfan Capsules SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
| Vinorelbine | Vinorelbine is available as a concentrate for solution for infusion | Click here to view the Vinorelbine SPC NoticeUpon clicking a link below you will leave www.medacpharma.co.uk. Links to all outside websites are provided as a resource to our visitors. medac Pharma accepts no responsibility for the content of other websites. |
For enquiries about any of our products, please contact the Medical Information Department on +44 (0)1786 458086 or email us at info@medacpharma.co.uk
Our normal enquiry service is available from 9am to 5pm Monday to Friday. However we do offer an emergency service outside these hours for urgent enquiries.
Apart from the desired effects, medical products can have side effects that are unpleasant or unintended. At medac, we continually collate information about side effects in order to monitor the benefit risk balance of each medication throughout its marketing lifecycle, and if necessary, can take action to better protect patient safety.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to medac Pharma at info@medacpharma.co.uk
We may contact you to gain further details about the report. However we are unable to provide medical advice. If you are concerned about any aspect of your treatment please discuss this with your healthcare professional (such as a doctor, nurse or pharmacist).
